Global Prosthetic Urology Devices Market - 2024-2031

Global Prosthetic Urology Devices Market - 2024-2031


Global Prosthetic Urology Devices Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2031 growing at a CAGR of YY% during the forecast period 2024-2031.

Prosthetic urology is a surgical field that provides life-altering therapies for its patients. These devices are designed to replace or augment the normal functioning of organs within the genitourinary tract. Implantation of prosthetic urology devices involves surgical procedures, and patients need to be in good general health to undergo these interventions.

Prosthetic urology procedures often require surgical intervention and aim to improve the quality of life and functionality for individuals affected by conditions such as erectile dysfunction, urinary incontinence, or anatomical abnormalities.

Market Dynamics

Increasing prevalence of urological disorders

The increasing prevalence of urological disorders such as erectile dysfunction, urinary incontinence, and congenital abnormalities acts as a significant driver for market growth. Artificial Urinary Sphincter (AUS) devices are used to treat urinary incontinence, particularly in men who have undergone prostate surgery.

For instance, according to the Urology Care Foundation, in the United States, between 25% and 33% of men and women experience urine incontinence. Millions of Americans are affected by this condition. Overactive bladder syndrome (OAB) affects over 33 million people and manifests as urgency, frequency, and urge incontinence.

Additionally, according to the Canadian Continence Foundation, 3.3 million Canadians nearly 10% of the population experience some form of urinary incontinence. Furthermore, significant growth drivers such as the increasing technological advancements, rising geriatric population, and increasing patient awareness are expected to drive the market in the forecast period.

High cost associated with penile implants

Implanting a penile prosthesis involves a surgical procedure, which includes the fees associated with the surgeon, anesthesiologist, and operating room. For instance, penile implant cost with package pricing typically runs between $16,000 and $19,000 and includes all associated fees. Thus, the above factors can hamper the market growth.

Segment Analysis

The global prosthetic urology devices market is segmented based on device type, indication, end user and region.

The penile prosthesis segment accounted for approximately 43.2% of the market share

The penile prosthesis segment is expected to hold the largest market share over the period forecast. It is surgically implanted into the penis to treat erectile dysfunction (ED) or other conditions that affect normal erectile function. Penile prostheses are designed to allow men to achieve a controlled and lasting erection for sexual activity.

For instance, in November 2023, Boston Scientific received FDA approval for a penile prosthesis pump. The AMS 700 IPP offers a treatment option for patients with erectile dysfunction. It features three parts. The system has a pair of cylinders implanted in the penis, a pump placed in the scrotum, and a saline reservoir in the lower abdomen.

Additionally, the Titan Penile Implant manufactured by Coloplast provides performance in both the operating room and the bedroom. Titan IPP is designed to overcome complications, address patient satisfaction, and allow to serve the diverse needs of more patients.

Geographical Analysis

North America is expected to hold a significant position in the global prosthetic urology devices market share

The global prosthetic urology devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.

North America has maintained a significant market proportion due to factors such as the rising prevalence of erectile dysfunction, technological advancements, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.

For instance, according to a National Institute of Health report, 52% of men in the United States between 40 and 70 years of age suffer from erectile dysfunction. It is estimated that at least 30 to 50 million men in the US and at least 150 million men globally have erectile dysfunction.

Additionally, it is currently estimated that up to 20% of Canadian men experience erectile dysfunction and 49% between the ages of 40 and 88 struggle with some form of sexual dysfunction. Hence, due to the above factors, there is a demand for penile prosthetics which is expected to drive the region’s growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global prosthetic urology devices market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, device launches, and consultations worldwide. With the outbreak of the pandemic, many treatment centers faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the prosthetic urology devices market is expected to be moderately affected over the forecast period.

Market Segmentation

By Device Type
• Penile Prosthesis
• Testicular Prosthesis
• Artificial Urinary Sphincter
• Urethral Stent Implants
• Others

By Indication
• Erectile Dysfunction
• Urinary Incontinence
• Bladder Augmentation
• Ureteral Obstruction
• Others

By End Users
• Hospital
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Boston Scientific Corporation, Zephyr Surgical Implants, Coloplast A/S, Advin Health Care, Rigicon Inc., Promedon GmbH, Palex Medical, Silimed, Cook Group Incorporated, Blueneem Medical Devices Pvt Ltd. among others.

Why Purchase the Report?
• To visualize the global prosthetic urology devices market segmentation based on device type, indication, end users and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global prosthetic urology devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global prosthetic urology devices market report would provide approximately 61 tables, 58 figures, and 185 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by Indication
3.3. Snippet by End Users
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of urological disorders
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. High cost associated with penile implants
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Device Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
7.1.2. Market Attractiveness Index, By Device Type
7.2. Penile Prosthesis*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Testicular Prosthesis
7.4. Artificial Urinary Sphincter
7.5. Urethral Stent Implants
7.6. Others
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication
8.2. Erectile Dysfunction*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Urinary Incontinence
8.4. Bladder Augmentation
8.5. Ureteral Obstruction
8.6. Others
9. By End Users
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
9.1.2. Market Attractiveness Index, By End Users
9.2. Hospital*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Boston Scientific Corporation
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Zephyr Surgical Implants
12.3. Coloplast A/S
12.4. Advin Health Care
12.5. Rigicon Inc.
12.6. Promedon GmbH
12.7. Palex Medical
12.8. Silimed
12.9. Cook Group Incorporated
12.10. Blueneem Medical Devices Pvt Ltd.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings